intra-articular steroid injections (usually hydrocortisone acetate) may work wonders, especially when combined with muscle exercises. Intra-articular steroids work particularly well in the knee, shoulder, and in tenosynovitis of the flexor tendons of the hand, and my use of them increases year by year, but never at more than three-month intervals. If repeated injection is needed I tend to use intra-articular radioisotopes to ablate the synovium in older patients and surgical synovectomy in younger ones.
Misuse or severe damage of one joint often leads to problems in nearby joints. Subluxed and painful metatarsal heads often predispose to knee or ankle problems, or a flexion deformity of the knee leads to hip or ankle problems in the opposite side.
Identification of the problem and correct treatment will reduce the need for unnecessary tablets.
Systemic corticosteroids
The vogue of systemic steroids in rheumatoid arthritis is long over. No one will deny the temporary benefit given to patients, but their long-term side effects outweigh their advantage, even in low dosage. Long-term trials show this effect to be lost after the first year, after which steroid-treated patients do worse. Most rheumatologists feel they see less "vasculitis" and less amyloidosis now that systemic steroids are used less, and the higher rate of wound infections, vertebral collapse, and skin fragility in steroid-treated patients deters me from using them.
Besides, many patients spontaneously request me not to start steroids. I do use them for two groups: firstly in wage-earners about to lose their job and housewives unable to cope while I wait for the gold or penicillamine to take effect; and secondly in patients in whom all else has failed and whose quality of life is poor. Ideally I try to use them on an alternate-day basis or as a morning daily dose of not more than 5 mg, as both of these minimise the steroid side effects more commonly seen with thrice daily or night-time regimens.
Remissions
Remission of inflammation may occur spontaneously or with disease-modifying drugs. At The overall level of agreement could be represented by the proportion of the total falling in cells a and d. This measure unfortunately turns out to depend more on the prevalence of the condition than on the repeatability of the method. This is because in practice it is easy to agree on a straightforward negative; disagreements depend on the prevalence of the difficult borderline cases. Repeatability (for the individual subject) is usually therefore defined as:
Number agreed positive a Number positive to either observer a+b+c This measure is largely independent of prevalence. It states the probability, given one positive test, of the second also being positive.
Epidemiological conclusions are more concerned with groups than individuals, and the above measure is less important than an estimate of observer or test bias:
Number positive to observer 1 a+c Number positive to observer 2 a+b Note that agreed positives are necessarily fewer than the positives for a single observer. Higgins Specificity-A specific test has few false-positives, and this quality is measured by d/b +d.
Systematic error-For epidemiological rates it is particularly important for the test to give the right total count of cases. This is measured by the ratio of the total numbers positive to the survey and the reference tests, or (a+b)/(a+c).
Predictive value-This is the proportion of test positives that are truly positive. It is important in screening, and will be discussed further in the article on that subject.
Sensitive or specific? A matter of choice If diagnostic criteria are stringent there will be few falsepositives but the test will be insensitive. Conversely, if criteria are relaxed there will be fewer false-negatives but the test will be less specific. In a recent survey of breast cancer alternative diagnostic criteria were compared in relation to a reference test (positive biopsy). Clinical palpation by a doctor yielded fewest false-positives (930%O specificity), but missed half the cases (50% sensitivity). Criteria for "a case" were then relaxed to include all the positives identified by doctor's palpation, nurse's palpation, or x-ray mammography: few cases were now missed (94% sensitivity), but specificity fell to 86%.
By choosing the right test and cut-off points it may be possible to get the balance of sensitivity and specificity that is best for the particular study. In a survey to establish prevalence this might be when false-positives just balance false-negatives. In a study to compare rates in different populations the absolute rates are less important, the primary concern being to avoid systematic bias: a specific test is likely to be preferred, even at the price of some loss of sensitivity.
Eventually this series will be collected into a book and hence no reprints will be available from the authors.
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